文献速递重症综合管理与镇静镇痛

Fcγ受体IIB缺陷小鼠:一种狼疮模型,内毒素耐受相关脓毒症易感性增加

Fc Gamma Receptor IIB Deficient Mice: A Lupus Model with Increased Endotoxin Tolerance-Related Sepsis Susceptibility.
PubMed 文献 · Shock · 2017-01-01
一句话结论在FcGRIIb-/-狼疮模型小鼠中,重复LPS给药诱导的内毒素耐受更显著,且与CLP脓毒症更严重相关,部分由巨噬细胞功能缺陷介导。

研究在FcGRIIb-/-狼疮模型小鼠(抑制性信号缺陷)中,于体内脓毒症模型和体外培养巨噬细胞中探讨内毒素耐受相关的炎症反应改变。第二次LPS注射(剂量为首次的5倍)后,FcGRIIb-/-与野生型小鼠的血清细胞因子浓度均未超过首次剂量水平,提示两种遗传背景均出现内毒素耐受反应,但FcGRIIb-/-小鼠首次与第二次LPS注射间的细胞因子水平差异更显著。LPS预处理(两次间隔给药)后CLP诱导的脓毒症在FcGRIIb-/-小鼠中更严重(以死亡率、血中细菌计数、血清细胞因子、肌酐和丙氨酸转氨酶衡量)。骨髓来源巨噬细胞经两次序贯LPS刺激后反应减弱,FcGRIIb-/-巨噬细胞较野生型巨噬细胞细胞因子产生减少、杀细菌活性降低。结论:重复LPS给药在FcGRIIb-/-小鼠体内外诱导量上更大的内毒素耐受反应,体内内毒素耐受与更严重脓毒症相关,至少部分由巨噬细胞功能障碍所致。

要点

  • FcGRIIb-/-与野生型小鼠第二次LPS注射(剂量为首次5倍)后血清细胞因子均未超过首次水平,提示两种遗传背景均出现内毒素耐受。
  • FcGRIIb-/-小鼠首次与第二次LPS注射间细胞因子水平差异较野生型更显著,提示内毒素耐受反应更强。
  • LPS预处理(两次间隔给药)后CLP诱导的脓毒症在FcGRIIb-/-小鼠更严重,死亡率、血中细菌计数、血清细胞因子、肌酐和丙氨酸转氨酶均更高。
  • FcGRIIb-/-骨髓来源巨噬细胞经两次序贯LPS刺激后细胞因子产生减少、杀细菌活性低于野生型巨噬细胞。
  • 体内内毒素耐受与更严重脓毒症相关,至少部分由巨噬细胞功能障碍所致。

适用人群与场景

  • FcGRIIb-/-小鼠(抑制性信号缺陷的狼疮模型)与野生型小鼠,用于体内脓毒症模型和体外骨髓来源巨噬细胞研究。

研究设计与关键结果

  • 研究类型为动物实验(体内脓毒症模型与体外细胞实验),比较FcGRIIb-/-小鼠与野生型小鼠。
  • 第二次LPS注射(剂量为首次的5倍)后,FcGRIIb-/-与野生型小鼠血清细胞因子浓度均未超过首次剂量水平,提示两种遗传背景均出现内毒素耐受反应。
  • FcGRIIb-/-小鼠首次与第二次LPS注射间细胞因子水平差异较野生型更显著。
  • LPS预处理(两次间隔给药)后CLP诱导的脓毒症在FcGRIIb-/-小鼠更严重,以死亡率、血中细菌计数、血清细胞因子、肌酐和丙氨酸转氨酶衡量。
  • FcGRIIb-/-骨髓来源巨噬细胞经两次序贯LPS刺激后细胞因子产生减少、杀细菌活性低于野生型巨噬细胞。

证据类型、等级与局限

  • 证据类型:动物实验(体内脓毒症模型与体外细胞实验)。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Hyper-elevated immune response of FcGRIIb-/- mice, a lupus model with an inhibitory-signaling defect, can become exhausted (less subsequent immune-response than the first response) with sequential lipopolysaccharide (LPS) stimulation. Endotoxin tolerance-related modifications of inflammatory response were investigated in FcGRIIb-/- mice in both an in vivo sepsis model and in vitro using cultured macrophages. Serum cytokine concentrations, after the second LPS injection (at 5-fold higher levels than the first dose), did not exceed the first dose levels in either FcGRIIb-/- or wild-type mice. These data indicated an endotoxin-tolerance response in both genetic backgrounds. However, the difference of cytokine levels between the first and second LPS injection was more prominent in FcGRIIb-/- mice. More importantly, CLP-induced sepsis after LPS-preconditioning (two separated doses of LPS administration) was more severe in FcGRIIb-/- mice (as measured by mortality rate, bacteria count in blood, serum cytokines, creatinine, and alanine transaminase). An attenuated response was demonstrated after two sequential LPS stimulations of bone-marrow-derived macrophages. Cytokine production was reduced and lower bacterial killing activity occurred with macrophages from FcGRIIb-/- mice relative to wild-type macrophages. Thus, there is a more prominent effect of endotoxin-tolerance in FcGRIIb-/- macrophages relative to wild-type. In conclusion, repeated-LPS administrations induced quantitatively greater endotoxin-tolerance responses in FcGRIIb-/- mice both in vivo and in vitro. Endotoxin-tolerance in vivo was associated with more severe sepsis, at least in part, due to macrophage-dysfunction.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Ondee T, Surawut S, Taratummarat S, et al. Fc Gamma Receptor IIB Deficient Mice: A Lupus Model with Increased Endotoxin Tolerance-Related Sepsis Susceptibility. Shock. 2017. PMID: 27849678. doi:10.1097/SHK.0000000000000796

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。